Novartis files application with FDA for Zometa
Novartis Pharmaceuticals has submitted an application to the Food and Drug Administration, seeking marketing authorization for Zometa in the treatment of bone complications associated with a broad range of tumor types. These include prostate and lung cancer, for which no bisphosphonate therapy is currently approved. The spread of cancerous cells from the original tumor to the bone, can lead to se...Zometa [Novartis Drug] For Treatment Of Paget’s Diseas
Results of the clinical study carried out by Professor Ian Reed and his team from the University of Auckland in New Zealand has found that the drug Zometa manufactured by Novartis treats Paget’s disease// far better than the drug Actonel produced by Procter and Gamble. Paget's disease is a condition in which the bones breaks or becomes weak faster than the normal and the new bone repl...